fbpx
Blue Symbol

LEARN MORE ABOUT OUR SCIENCE

Kidney Cancer

For over thirty years, Verthermia® has worked to perfect the procedure of HEATT®. We prioritize safety by closely monitoring vitals during the entire cancer treatment procedure. As we heat the body, we target cancerous cells as blood circulates.  HEATT® employs a patient’s own blood for whole-body hyperthermia – a process that is non-invasive and completely free from any chemicals.

kidney cancer treatment

Revolutionizing Cancer
Treatment

What is HEATT®?

Verthermia® provides Hyperthermic Extracorporeal Applied Tumor Therapy (HEATT®), a patented, whole-body hyperthermia cancer treatment to extend and enhance daily living for cancer patients.

Why 42° Celsius?

42° C has been scientifically identified as an optimal temperature because it can damage cancer cells while providing minimal harm to healthy cells.

Nequeporro Quisquam

How Does HEATT®
Treatment Work?

Hyperthermia works by increasing the temperature of the cancer cells, accomplishing direct cell death, cell damage, or slowing the cancer cell growth of susceptible cells.

Speak with real oncologists
Orange Symbol

Why
Choose
HEATT®?

HEATT® stands out from other hyperthermia treatments due to its unique approach of heating the blood directly, closely controlling body temperature while restoring electrolyte balance and fluid levels. Instead of conduction or convection (external) heating methods, HEATT® employs a patient’s own blood to distribute heat for whole-body hyperthermia – a process that is non-invasive and completely free from any chemicals.

Play Video

INCREASING IMMUNITY AND KILLING CANCER CELLS

Non-Invasive Mechanics

HEATT® provides whole-body hyperthermia cancer treatment through a perfusion based procedure that does not involve surgical resection of tumors or radiation.

DATA-DRIVEN TREATMENT

At Verthermia®, we believe that everyone should have access to effective cancer treatments. Our clinical trials to date have shown positive patient outcomes with whole-body hyperthermia treatment.

Lung Cancer Results

Verthermia® trial patients with unresponsive lung cancer exceeded average life expectancy after receiving HEATT®.

Advanced Cancer Results

Testimonials

Scroll to Top